Drug Points: tachycardia associated with moxifloxacin
- PMID: 11141146
- PMCID: PMC26602
- DOI: 10.1136/bmj.322.7277.23
Drug Points: tachycardia associated with moxifloxacin
References
-
- Stahlmann R, Schwabe R. Safety profile of grepafloxacin compared with other fluorochinolones. J Antimicrob Chemother. 1997;40(suppl A):83–92. - PubMed
-
- Lode H, Vogel F, Elies W. Grepafloxacin: a review of its safety profile based on clinical trials and post marketing surveillance. Clin Ther. 1999;21:61–74. - PubMed
-
- Takayama S, Hirohashi M, Kato M, Shimada H. Toxicity of quinolone antimicrobial agents. J Toxicol Environ Health. 1995;45:1–45. - PubMed
-
- Janssen MC, Smits P, Reyenga J, Thien T. Acute effects of flosequinan (BTS 49465) in untreated moderate to severe hypertension. J Hum Hypertens. 1995;9:363–368. - PubMed
-
- Balfour JA, Lamb HM. Moxifloxacin. A review of its clinical potential in the management of community-acquired respiratory tract infections. Drugs. 2000;59:115–139. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources